NEW YORK (GenomeWeb) – Software firm Syapse said today that it raised $10 million in a Series B financing round led by Safeguard Scientifics with participation from Series A investor The Social+Capital Partnership.

Syapse said that it will use the funds to expand its sales, marketing, and client services, as well as further accelerate product development. The funds will also support the firm's efforts to provide its Precision Medicine Data platform to healthcare providers, enabling them to use genomics and clinical data in their treatment decisions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.